Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JXSL2101055	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-07-08	Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd			view
JXSB2300062	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2023-05-22	Msd Ireland;Merck Sharp & Dohme Corp			view
JXSB2101079	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2021-10-27	Msd Ireland;Merck Sharp & Dohme Corp			view
JXSL2400221	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2024-11-14	Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd			view
JXSB2200056	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2022-05-07	Msd Ireland;Merck Sharp & Dohme Corp			view
JXSL2101135	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-22	Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd			view
JXSB2101018	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-06-03	Msd Ireland;Merck Sharp & Dohme Corp			view
JXSB2300125	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2023-10-14	Msd Ireland;Merck Sharp & Dohme Ltd			view
JXSS2500051	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2025-04-28	Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd			view
JXSB2300001	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-01-04	Msd Ireland;Merck Sharp & Dohme Ltd			view
JTS2400017	favezelimab帕博利珠单抗注射液	favezelimab;pembrolizumab	Injection	Biological Products	Disposable Import Drug Application	2024-03-12	Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd			view
JXSS2101033	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-26	Msd Ireland;Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd			view
JYSB2000289	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2020-06-28	Msd Ireland;Merck Sharp & Dohme Corp	In Review	2020-06-25	view
JXSB2101016	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-06-02	Msd Ireland;Merck Sharp & Dohme Corp			view
JYSB2400009	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2024-01-18	Msd Ireland;Merck Sharp & Dohme Ltd			view
JXSS2300028	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2023-03-29	Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd			view
JYSB1800259	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2018-11-28	Msd Ireland;Merck Sharp & Dohme Corp	In Review	2018-11-27	view
JXSL2101109	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-09-14	Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd			view
JXSB2400095	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2024-07-12	Msd Ireland;Merck Sharp & Dohme Ltd			view
JXSB2101078	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-10-26	Msd Ireland;Merck Sharp & Dohme Corp			view